
Takeda Pharmaceutica
4502
End-of-day quote Tokyo - 02/19
4500JPY
-0.18%
Income Statement Evolution
Annual Income Statement Data
Actuals in M JPY | Estimates in M JPY | |
Fiscal Period March | 2018 | 2019 |
Sales | 1 770 531 | 2 463 170 |
EBITDA | 437 460 | 538 767 |
Operating profit (EBIT) | - | - |
Pre-Tax Profit (EBT) | 217 205 | 221 296 |
Net income | 186 886 | 179 678 |
EPS ( JPY ) | 239 | 134 |
Dividend per Share ( JPY ) | 180 | 180 |
Yield | 3,47% | 3,99% |
Announcement Date | 05/14/2018 06:00am | - |
Finances - Leverage
Actuals in M JPY | Estimates in M JPY | |
Fiscal Period March | 2018 | 2019 |
Debt | 610 494 | 5 789 399 |
Finance | - | - |
Operating income (EBITDA) | 437 460 | 538 767 |
Leverage (Debt/EBITDA) | 1,40x | 10,7x |
Capital Expenditure | 67 005 | 142 914 |
Book Value Per Share (BVPS) | 2 557 JPY | 3 736 JPY |
Cash Flow per Share | 490 JPY | 314 JPY |
Announcement Date | 05/14/2018 06:00am | - |
Balance Sheet Analysis
Financial Ratios
|
Price Earning Ratio
BNA & Dividende